Holen Sie sich die Stockscreener-App
3.445
3.77%
-0.135
Schlusskurs vom Vortag:
$3.58
Offen:
$3.51
24-Stunden-Volumen:
54,734
Relative Volume:
0.02
Marktkapitalisierung:
$6.58M
Einnahmen:
$389.00K
Nettoeinkommen (Verlust:
$-13.13M
KGV:
-3.3372
EPS:
-1.0323
Netto-Cashflow:
$-11.90M
1W Leistung:
+903.50%
1M Leistung:
+916.82%
6M Leistung:
+446.83%
1J Leistung:
+29.51%
1-Tages-Spanne:
$3.30
$3.54
1-Wochen-Bereich:
$0.31
$3.91
52-Wochen-Spanne:
$0.2637
$3.91
Collplant Biotechnologies Ltd Stock (CLGN) Company Profile
Firmenname
Collplant Biotechnologies Ltd
Sektor
Branche
Telefon
-
Adresse
-
Compare CLGN vs VRTX, REGN, ARGX, MRNA, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLGN
Collplant Biotechnologies Ltd
|
3.48 | 6.77M | 389.00K | -13.13M | -11.90M | -1.0323 |
VRTX
Vertex Pharmaceuticals Inc
|
520.57 | 134.06B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
806.10 | 83.43B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,006.31 | 63.00B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
137.51 | 56.02B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
209.55 | 44.44B | 742.00K | -1.37B | -1.07B | -7.0731 |
Collplant Biotechnologies Ltd Stock (CLGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-02-17 | Eingeleitet | Alliance Global Partners | Buy |
Collplant Biotechnologies Ltd Aktie (CLGN) Neueste Nachrichten
CollPlant (NASDAQ: CLGN) gives CFO 510,372 RSUs with 5-year vesting - Stock Titan
CollPlant Adds LightSolver Founder to Board After Closing Photonic Computing Acquisition - TipRanks
CollPlant Biotechnologies LtdADR Key Financial Ratios – Valuation, Profitability & More - Value Research
Biotech CollPlant (CLGN) extends into photonic computing with LightSolver board move - Stock Titan
CollPlant adds LightSolver CEO Dr. Ruti Ben Shl... - Pluang
A physicist who helped create light-based computing joins CollPlant's board - Stock Titan
CollPlant Finalizes LightSolver Acquisition with $5 Million Equity Investment - Kalkine Media
CollPlant (CLGN) moves into photonic computing with LightSolver acquisition - Stock Titan
CLGN Looks 14.7% Overvalued on GF Value™ - GuruFocus
collplant completes acquisition of lightsolver, entering the photonic computing sector - Fidelity Investments
COLLPLANT COMPLETES ACQUISITION OF LIGHTSOLVER, ENTERING THE PHOTONIC COMPUTING SECTOR - finance.yahoo.com
CollPlant Biotechnologies acquires laser-based computing startup LightSolver - Data Center Dynamics
CollPlant to Implement 1-for-10 Reverse Stock Split - marketscreener.com
CLGN Looks 24.2% Overvalued on GF Value™ - GuruFocus
Reverse split ahead for CollPlant (NASDAQ: CLGN) to help keep its Nasdaq listing - Stock Titan
COLLPLANT ANNOUNCES REVERSE SHARE SPLIT - PR Newswire
CollPlant to acquire LightSolver in photonic computing deal - Engineering.com
CollPlant Buys LightSolver in Bet on Laser-Based Computing - finance.biggo.com
CollPlant Biotechnologies Ltd. signed a definitive agreement to acquire Lightsolver Ltd. for $84.2 million. - marketscreener.com
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
CollPlant agrees LightSolver photonic computing deal - grafa.com
Why CollPlant Biotechnologies (CLGN) Stock Is Up Today - quiverquant.com
CollPlant Acquires LightSolver, Enters Supercomputing and Photonic Computing Markets - HPCwire
CollPlant to Acquire LightSolver, Pivoting Into Photonic Supercomputing - TipRanks
COLLPLANT IS ACQUIRING LIGHTSOLVER- ENTERS SUPERCOMPUTING AND PH - GuruFocus
CollPlant Biotechnologies (NASDAQ: CLGN) files foreign issuer update - Stock Titan
CollPlant To Acquire LightSolver As Laser Processing Unit Targets 2028 Commercial Launch - Pulse 2.0
CLGN Looks 14.5% Overvalued on GF Value™ - GuruFocus
COLLPLANT IS ACQUIRING LIGHTSOLVER- ENTERS SUPERCOMPUTING AND PHOTONIC COMPUTING MARKETS - PR Newswire
Press Release: COLLPLANT IS ACQUIRING LIGHTSOLVER- ENTERS SUPERCOMPUTING AND PHOTONIC COMPUTING MARKETS - 富途牛牛
CollPlant (CLGN) Financial Results: The Available Earnings Metric Delivers a Miss for This Review; Share Response: Shares Rise 0.25% for the Current SessionBook Value Growth - vinanet.vn
Inside Loewenbaum's capped warrant-backed bet on CollPlant (CLGN) - Stock Titan
Bioink Market Set to Booming Growth 2026-2033 | CELLINK, - openPR.com
What Could CollPlant (NASDAQ:CLGN) Results Signal for Investors? - Kalkine Media
CollPlant (CLGN) Financial Update: The Available Earnings Metric Delivers a Miss for the Current Session; Shares Move Lower 1.66% in the Available RecordProfit Announcement - vinanet.vn
CollPlant Shareholders Approve All Proposals at August 18 Extraordinary Meeting - TipRanks
CollPlant (CLGN) shareholders back both August EGM items - Stock Titan
CLGN Q4 2025 Earnings: Wider-than-Expected Loss Highlights Pre-Revenue R&D PushPre-Earnings Drift - vinanet.vn
CollPlant Biotechnologies Bolsters Authorized Share Capital and Validates Resale Shares After July Private Placement - TipRanks
CollPlant Biotechnologies (CLGN) lifts share capital, files new resale opinion - Stock Titan
CLGN Q4 2025 Earnings: Wider-Than-Expected Loss Pressures Shares as R&D Investment ContinuesTrough Earnings Signal - vinanet.vn
CLGN Q4 2025 Earnings: Wider-than-Expected Loss Sends Shares Down 9%CFO Commentary Report - vinanet.vn
Loewenbaum group holds 33% CollPlant (CLGN) stake after warrant deal - Stock Titan
CollPlant Shareholders Approve Proposal at Extraordinary General Meeting - theglobeandmail.com
CollPlant Biotechnologies (NASDAQ: CLGN) reverse split to boost share price - Stock Titan
CollPlant Biotechnologies (CLGN) holders buy 1,764,706 shares plus new warrants - Stock Titan
Collplant Biotechnologies Ltd (CLGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Collplant Biotechnologies Ltd - TradingKey
CLGN|Collplant Biotechnologies Ltd|Price:0.305|Chg%:-0.010 - TradingKey
Collplant Biotechnologies Ltd (CLGN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Collplant Biotechnologies Ltd (CLGN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Finanzdaten der Collplant Biotechnologies Ltd-Aktie (CLGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.29%
4.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):